With the goal of supporting stronger risk assessments to address emerging food chemical risks, the European Food Safety Authority (EFSA) reviewed existing data sources; data gaps and challenges; and recommendations for improving data availability, quality, and interoperability.
The three-year partnership will focus on driving food safety, sustainability, and resiliency, aligned with One Health principles, by leveraging advanced technological tools and science.
Amid the ongoing global infant formula recall due to possible cereulide contamination, some countries have reported cases of mostly mild gastrointestinal illness in infants who had consumed infant formula, but confirming cereulide exposure is a challenge.
A high proportion of Campylobacter and Salmonella from food-producing animals across Europe are resistant to antimicrobials that are important to human medicine. Escherichia coli resistance to last-resort carbapenems is growing.
EFSA conducted a safety reevaluation for the sweetener sucralose, resulting in no change to the acceptable daily intake (ADI). EFSA also considered a proposed extension for the use of sucralose in fine bakery wares, but was unable to determine its safety.
An EFSA survey found that only one in ten respondents reported awareness about the health risks of seafood, and one-third of seafood consumers ate species high in mercury three or more times a week.
Per EFSA’s latest annual report on veterinary drug residues in food-producing animals and their products, only 0.13 percent of samples were non-compliant in 2024.
EFSA established a provisional safe intake level for adults for CBD as a novel food while highlighting that data gaps continue to exist regarding possible effects of CBD on the liver and the endocrine, nervous, and reproductive systems.
Responding to the global infant formula recall affecting products from Nestlé, Danone, and other producers, the European Food Safety Authority (EFSA) has determined concentrations of cereulide in formula that pose a safety concern to guide risk management decisions that protect public health.
Following a global recall of infant formula products due to cereulide toxin contamination, EU officials are taking steps to prevent illnesses from cereulide-tainted formula in the future. Cases of mild illness associated with recalled product have been reported in Europe.
